Reclast vs. Forteo
See how Reclast and Forteo compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Reclast is a once-a-year (or once-every-two-years) IV infusion, while Forteo is a daily self-injection you give yourself at home.
Reclast slows bone breakdown, while Forteo is one of the few therapies that actually builds new bone, so doctors often choose based on how severe the osteoporosis is.
Forteo's list price runs far higher per month than Reclast's per-infusion cost, which can be a major factor in choosing between them.
Reclast vs. Forteo Drug Summary
Reclast
Reclast (zoledronic acid) is a bisphosphonate given as an IV infusion that slows the breakdown of bone. It treats and prevents osteoporosis after menopause, increases bone mass in men, treats glucocorticoid-induced osteoporosis, and treats Paget's disease of bone. Most patients get one infusion a year, or once every two years for prevention.
Forteo
Forteo (teriparatide) is a parathyroid hormone analog given as a daily self-injected pen that builds new bone rather than just slowing bone loss. It's approved for postmenopausal women, men with primary or hypogonadal osteoporosis, and people on long-term glucocorticoids, all at high fracture risk. Because it's an anabolic agent, it's often reserved for more severe or high-risk cases.
Reclast vs. Forteo Side Effects
Reclast
Forteo
Reclast vs. Forteo Dosage
Reclast
Forteo
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg IV infusion | At the start |
| Maximum dose | 5 mg IV infusion | Same as starting |
| Dose changes | None | Fixed dose |
| STAGE | DOSE | WHEN |
| Starting dose | 20 mcg once daily | At the start |
| Maximum dose | 20 mcg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Reclast
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg IV infusion | At the start |
| Maximum dose | 5 mg IV infusion | Same as starting |
| Dose changes | None | Fixed dose |
Forteo
| STAGE | DOSE | WHEN |
| Starting dose | 20 mcg once daily | At the start |
| Maximum dose | 20 mcg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Reclast vs. Forteo Indications
Reclast
Reclast is FDA-approved to treat and prevent osteoporosis in postmenopausal women, increase bone mass in men with osteoporosis, and treat or prevent glucocorticoid-induced osteoporosis. It's also approved for Paget's disease of bone. Doctors often choose it for patients who want to avoid daily pills or injections.
Treatment of osteoporosis in postmenopausal women
Prevention of osteoporosis in postmenopausal women
Increase bone mass in men with osteoporosis
Treatment and prevention of glucocorticoid-induced osteoporosis
Forteo
Forteo treats osteoporosis in postmenopausal women and men at high fracture risk, and glucocorticoid-induced osteoporosis in men and women at high risk. It is not approved for patients with open growth plates or other conditions that raise the baseline risk of bone cancer. This makes it an option mainly for people who need active bone-building rather than maintenance.
Osteoporosis in postmenopausal women at high fracture risk
Osteoporosis in men at high fracture risk
Glucocorticoid-induced osteoporosis in high-risk patients
Not approved for patients with open growth plates
Reclast vs. Forteo Pros and Cons
Reclast
Reclast's once-a-year or once-every-two-years infusion suits patients who struggle with daily routines, but it must be given in a clinic and requires adequate kidney function. It slows bone breakdown rather than building new bone, so it may be less suited to people with already severe osteoporosis.
Pros
Only 1 infusion needed per year, or every 2 years for prevention
No at-home needles or daily routine to remember
Roughly $600 to $1,600 per infusion without insurance, far less than a year of Forteo
Decades of use as an established bisphosphonate
Cons
Must be given by IV infusion at a clinic or hospital
Common flu-like reaction (fever, muscle aches) in the days after infusion
Not for patients with significant kidney impairment
Only slows bone loss, does not build new bone
Forteo
Forteo actively builds new bone, making it an option for patients with severe osteoporosis or those who have already fractured on other therapies. It requires a daily self-injection and carries one of the higher price tags among osteoporosis treatments.
Pros
Builds new bone rather than only slowing bone loss
Option for men with primary or hypogonadal osteoporosis
No infusion-related flu-like reaction
Self-injected at home, no clinic visit required for dosing
Cons
Requires a self-injection every single day
Roughly $4,590 to $5,100 per month without insurance, far more than Reclast's annual cost
Early doses can cause a brief drop in blood pressure when standing
Avoided in patients at increased baseline risk of bone cancer
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.